Radiomics-Based AI Models Can Detect PDAC From Prediagnostic CT
WEDNESDAY, Aug. 10, 2022 (HealthDay News) — Radiomics-based machine learning (ML) models can detect pancreatic ductal adenocarcinoma (PDAC) from prediagnostic computed tomography (CT) images, according to a study published online June 30 in Gastroe…
Learn MoreNeoadjuvant mFOLFIRINOX Studied for Borderline Resectable PDAC
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — For patients with borderline resectable pancreatic ductal adenocarcinoma (PDAC), favorable overall survival was observed following treatment with eight cycles of neoadjuvant modified FOLFIRINOX (mFOLFIRINOX)…
Learn MoreNeoadjuvant mFOLFIRINOX Studied for Borderline Resectable PDAC
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — For patients with borderline resectable pancreatic ductal adenocarcinoma (PDAC), favorable overall survival was observed following treatment with eight cycles of neoadjuvant modified FOLFIRINOX (mFOLFIRINOX)…
Learn MoreLas pruebas regulares valen la pena para las personas con un riesgo alto de cáncer de páncreas
MIÉRCOLES, 20 de julio de 2022 (HealthDay News) — Con frecuencia, el cáncer de páncreas tiene un pronóstico lúgubre, pero un nuevo estudio encuentra que realizar pruebas de detección a las personas con un riesgo alto puede encontrar la enfermedad tem…
Learn MoreRegular Screening Pays Off for People at High Risk for Pancreatic Cancer
WEDNESDAY, July 20, 2022 (HealthDay News) — Pancreatic cancer often has a dismal prognosis, but a new study finds that screening high-risk people can catch the disease early and extend lives.Researchers at eight U.S. medical centers found that annual…
Learn More